article thumbnail

Velocity Acquires Site in Berlin, Fourth in Germany

Velocity Clinical Research

Katrein Dreykluft The business economist and nurse, Katrein Dreykluft, founded Klinische Forschung Berlin GbR almost 25 years ago alongside her husband Tilman Dreykluft, MD, as well as Thomas Zöller, MD and his wife, Isabelle Schenkenberger, MD. Multi-Specialty Experience The three doctors specialize in different therapeutic areas.

article thumbnail

[Webinar] How biotech companies can improve clinical supply planning and distrib…

The Pharma Data

. Sign up today to understand how to implement an affordable supply-forecasting tool into your clinical supply chain. Irena Seredina holds a Medical Doctor, honors diploma and a Master of Science degree in Health Economics. During her medical practice, Seredina worked in clinical research as an investigator.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advances in Rare Disease Drug Development: Disease Biology, Regulatory Support, Building Relationships and the Patient Voice

XTalks

Prior to joining Calliditas Therapeutics as CMO, he held roles at GlaxoSmithKline (GSK) and Takeda, focusing on clinical and business development in rare diseases. I’ve had a great passion for drug development in rare diseases,” says Dr. Philipson, underscoring a commitment that would shape his career’s trajectory.

article thumbnail

Patient involvement in trial design: looking to the future

pharmaphorum

That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s Clinical Research Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. We also need to remember that patients still like going to doctors. Listening to patients.

Trials 123
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field.